BioAtla GAAP EPS of -$0.16, revenue of $2M
Source: SeekingAlpha
2026-03-31 16:51:07 ET
More on BioAtla
Read the full article on Seeking Alpha
For further details see:
BioAtla GAAP EPS of -$0.16, revenue of $2M
BioAtla Inc.
NASDAQ: BCAB
BCAB Trading
-4.29% G/L:
$3.35 Last:
89,341 Volume:
$3.51 Open:
BCAB Latest News
May 18, 2026 06:45:00 am
Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
March 31, 2026 04:05:00 pm
BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
BCAB Stock Data
$12,399,342
60,967,643
5.51%
17
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
